14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
MATV vs CLMT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Mativ Holdings, Inc. (MATV) is the stronger overall head-to-head candidate over Calumet, Inc. (CLMT) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). MATV carries a Unified Composite Score of 52.8/100 (HOLD) at $11.67 (10.2x Forward P/E, 4.1% operating margin), whereas CLMT carries 49.4/100 (HOLD) at $31.72 (32.4x Forward P/E, -1.7% operating margin).
Growth vs. Quality Trade-Off: MATV earns the overall head-to-head edge with a stronger Unified Composite Score (52.8/100 HOLD vs. CLMT 49.4/100 HOLD) and 0.77β · 52% Vol risk profile, whereas CLMT leads top-line expansion (+56.1% YoY revenue growth, 0.65x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: MATV is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.8); meanwhile CLMT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 20.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MATV vs CLMT. Trailing 12-month operating profitability (MATV 4.1% vs CLMT -1.7%) and valuation multiples (MATV 10.2x vs CLMT 32.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Specialty Chemicals value chain with $3.0B market capitalization and -1.7% operating margin.
OpEx & R&D Reinvestment11.1% of Rev ($577M)
90D Engineering Disclosures0 Published
Investor FAQ MATV vs CLMT Key Questions & Quantitative Answers
As of Nov 16, 2026, Mativ Holdings, Inc. (MATV) is the stronger overall head-to-head candidate over Calumet, Inc. (CLMT) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). MATV carries a Unified Composite Score of 52.8/100 (HOLD) at $11.67 (10.2x Forward P/E, 4.1% operating margin), whereas CLMT carries 49.4/100 (HOLD) at $31.72 (32.4x Forward P/E, -1.7% operating margin). Growth vs. Quality Trade-Off: MATV earns the overall head-to-head edge with a stronger Unified Composite Score (52.8/100 HOLD vs. CLMT 49.4/100 HOLD) and 0.77β · 52% Vol risk profile, whereas CLMT leads top-line expansion (+56.1% YoY revenue growth, 0.65x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: MATV is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.8); meanwhile CLMT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 20.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CLMT leads the Growth & Scale pillar: MATV posts -2.8% YoY revenue growth and N/A YoY earnings growth on $1.97B TTM revenue (19.4% gross margin, 4.1% operating margin), compared with CLMT at +56.1% YoY revenue growth and -19.2% YoY earnings growth on $5.20B TTM revenue (9.4% gross margin, -1.7% operating margin). On trailing 12-month operating scale, MATV generates $1.97B in USD-normalized revenue versus $5.20B for CLMT. In operating R&D and SG&A reinvestment, MATV deploys 15.3% of Rev ($302M) (0 90-day corporate R&D disclosures) versus 11.1% of Rev ($577M) (0 disclosures) for CLMT.
MATV screens cheaper on headline valuation multiples. MATV trades at 10.2x Forward P/E, 7.2x Trailing P/E, 1.84x PEG, and 0.3x EV/Revenue (10.9% EBITDA margin), whereas CLMT trades at 32.4x Forward P/E, 32.4x Trailing P/E, 0.65x PEG, and 1.0x EV/Revenue (5.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MATV (21.2% ROE) versus CLMT (-1172.2% ROE) capital efficiency.
In options market volatility and institutional positioning, MATV carries 56.0% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.77β · 52% Vol realized risk). By comparison, CLMT carries 62.8% implied volatility (50th %ile, Balanced (25th–60th %ile)), a 0.61x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (-0.26β · 68% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.